Riskpilot← Back to searchSign inGet full accessElaris Biosciences AB
ABActiveOrg 5595418152Economic activity was not specified by tax authority · NACE 0000Est. 20250 employees
Revenue
—
EBITDA margin
—
Equity ratio
—
Financial strength
Net profit
—
0 employees
| Revenue | — | — |
| EBITDA | — | — |
| Net profit | — | — |
| Total assets | — | — |
| Equity | — | — |
| Employees | 0 | — |
Legal name
Elaris Biosciences AB
Org number
5595418152
Legal form
Aktiebolag
NACE code
0000 · Economic activity was not specified by tax authority
Founded
25 augusti 2025
Share capital
—
Employees
0
VAT registered
No
Audit selected
No
Last report
—
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva livsmedels-, jordbruks- och bioteknik- industri. Företaget tillhandahåller konsulttjänster inom jordbruk, mat, bioteknik och till universitet. Bolaget tillhandahåller bioinformatikstöd och kontraktsforskning. Aktiviteter inkluderar forskning, utveckling, produktion och försäljning av produkter och tjänster såsom ribonukleinsyra baserade lösningar, enzymer, biologiska växtskyddsmedel, nyttiga mikrober, biostimulanter och digitala Al-baserade applikationer. Företaget erbjuder också analystjänster, nästa generations sekvensering, experimentell design, testning, utbildning och rådgivning för hållbart jordbruk, växtskydd och livsmedels- innovation. Samt därmed förenlig verksamhet.
Address
Email
startaforetag@fortnox.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item |
|---|
| Revenue |
| Staff expenses |
| EBITDA |
| Depreciation & amort. |
| EBIT |
| Net financials |
| Profit before tax |
| Tax |
| Net profit |
| Item |
|---|
| Total assets |
| Equity |
| Long-term debt |
| Short-term debt |
| Total debt |
EBITDA margin
%
This company
15.8%
Market median
-NaN% vs market
Equity ratio
%
This company
38.2%
Market median
-NaN% vs market
Return on equity
%
This company
18.4%
Market median
-NaN% vs market
Net profit margin
%
This company
8.1%
Market median
-NaN% vs market
Asset turnover
×
This company
1.12×
Market median
-NaN% vs market
Debt / equity
×
This company
0.62×
Market median
-NaN% vs market
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2025 | |
| Chairman | 2025 | |
| Deputy Board Member | 2025 | |
| Former (4) | ||
| Deputy Board Member | 2025 – 2025 | |
| Deputy Board Member | 2025 – 2025 | |
| Deputy Board Member | 2025 – 2025 | |
| Board of Directors | 2025 – 2025 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Elaris Biosciences AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Emelie Karin Marie Holstein | Deputy Board Member | 0 companies |
| Stina Maria Selldén | Deputy Board Member | 0 companies |
| Ruparamadurganagacharan Konakalla | Board of Directors | 0 companies |
| Erik Alexander Stötsberg | Deputy Board Member | 0 companies |
| Ramesh Raju Vetukuri | Chairman | 0 companies |
| Laura Vetukuri | Deputy Board Member | 0 companies |
| Mikaela Jenni Berglund | Board of Directors | 0 companies |